Clinical Trial
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
ClinicalTrials.gov9/23/2021·09/23/21🌐 Europe
Summary
This study develops neurofeedback protocols using implanted deep brain stimulation electrodes in patients with epilepsy, Parkinson's disease, and essential tremor. Participants learn to voluntarily modulate their own brain activity through real-time feedback from intracranial recordings, potentially enhancing DBS therapy outcomes.
Why it matters
Combining neurofeedback with implanted DBS electrodes represents a paradigm shift toward patient-controllable neuromodulation. This bidirectional brain-computer interface approach could reduce stimulation side effects while maintaining therapeutic benefit across multiple neurological conditions.
#Phase 2#Epilepsy#Parkinson's#BCI#Neural Recording#Deep Brain Stimulation#Closed-Loop#Europe
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in